Acorda Therapeutics Cdt buy StockNews.com
Start price
07.05.23
/
50%
€0.61
Target price
07.05.24
-
Performance (%)
-22.31%
End price
08.05.24
-
Summary
This prediction is currently being closed. The price of Acorda Therapeutics Cdt has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.31%. StockNews_com has a follow-up prediction for Acorda Therapeutics Cdt where he still thinks Acorda Therapeutics Cdt is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Acorda Therapeutics Cdt | - | - | - |
iShares Core DAX® | -0.383% | 5.021% | 16.188% |
iShares Nasdaq 100 | 1.248% | 4.007% | 36.579% |
iShares Nikkei 225® | 0.525% | -0.109% | 12.378% |
iShares S&P 500 | 0.640% | 3.649% | 28.752% |
Comments by StockNews_com for this prediction
In the thread Acorda Therapeutics Cdt diskutieren
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
In the thread Trading Acorda Therapeutics Cdt
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.58
31.05.23
31.05.23
-
31.05.24
31.05.24
-18.97%
02.06.23
02.06.23
Stopped prediction by StockNews_com for Acorda Therapeutics Cdt
Acorda Therapeutics Cdt
Start price
Target price
Perf. (%)
€0.41
29.04.23
29.04.23
-
29.04.24
29.04.24
10.78%
30.04.24
30.04.24